I understand that, IMO this response just sounds like a giant rationalization. How'd that work out for the J&J vaccine? I'm a "proof is in the pudding", "show me, not tell me", "real world over academic world" etc. I'm a business guy and your a science guy (I think), so we're often not going to have the same perspective. Pluses and minuses to both perspectives I guess. I'll use my "compelling" argument again. I don't think the vaccines are effective enough to justify them being mandated and having people lose their jobs. The results in the real world have proven that unequivocally as the virus has spread unabated among the unvaccinated.Clinical trails are evaluated within agencies and the results are made available to the public. There are search engines to find them. They are not considered a journal publication per se; there is not publisher, there is no paywall, you don't find them on preprint servers.. Most of the time clinical trails will not generate the type of findings that are of interest to the broader scientific community; they are just descriptive. Sometimes the results of clinical trails, if basic scientific information or new technological progress, comes out of them they are submitted for publication. In that case they are evaluated will be evaluated through the traditional academic peer review process. But that is in addition to, not in lieu of, regulatory review.
For children, the equation is a little different. Healthy children have less than miniscule risk from serious consequences from the virus. However, long term consequences, if any, are unknown from this virus in the U12 age group, as are the long term consequences, if any, of the vaccine. This is not lost on parents based on the fact that 5-12 is only 30% vaccinated and 6mo-4 is only 1 1/2%. This "appeal to authority" is not as strong with the general public as it is with academic types. It has become significantly less strong the last 2 years due to the lack of credibility we seen from the experts.